Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | D. Planchard, B. Besse, T. Min Kim, E. A. Quoix, P. J. Souquet, J. Mazieres, F. Barlesi, H. J.M. Groen, E. F. Smit, C. S. Baik, B. Chul Cho, R. J. Kelly, M. A. Socinski, S. Novello, J. R. Rigas, V. Giannone, A. M. D'amelio, P. Zhang, B. Mookerje, B.E. Joh | ||||||||||||
Title | Updated survival of patients (pts) with previously treated BRAF V600E–mutant advanced non-small cell lung cancer (NSCLC) who received dabrafenib (D) or D + trametinib (T) in the phase II BRF113928 study. | ||||||||||||
|
|||||||||||||
URL | http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9075 | ||||||||||||
Abstract Text |